Booth Bruce

Insider Buys Quantity –
2
2024-06-13SaleKymera Therapeutics, Inc.
KYMR
director
10,200
0.0168%
$34.98$356,796-9.81%
2024-06-12SaleKymera Therapeutics, Inc.
KYMR
director
16,740
0.028%
$35.45$593,378-8.57%
2024-03-15SaleKymera Therapeutics, Inc.
KYMR
director
71,764
0.1171%
$40.46$2.9M-13.23%
2024-03-14SaleKymera Therapeutics, Inc.
KYMR
director
55,779
0.0861%
$39.98$2.23M-10.78%
2024-03-13SaleKymera Therapeutics, Inc.
KYMR
director
139,255
0.2271%
$42.23$5.88M-16.65%
2024-03-12SaleKymera Therapeutics, Inc.
KYMR
director
162,918
0.2674%
$41.98$6.84M-15.72%
2024-03-11SaleKymera Therapeutics, Inc.
KYMR
director
51,184
0.0849%
$42.85$2.19M-16.61%
2023-01-12SaleKymera Therapeutics, Inc.
KYMR
director
98,720
0.153%
$30.29$2.99M-26.07%
2023-01-11SaleKymera Therapeutics, Inc.
KYMR
director
27,754
0.0478%
$29.96$831,510-16.97%
2022-12-15SaleKymera Therapeutics, Inc.
KYMR
director
3,278
0.0061%
$30.00$98,340-11.97%
2022-12-14SaleKymera Therapeutics, Inc.
KYMR
director
378,966
0.6933%
$31.37$11.89M-17.08%
2022-11-03SaleKymera Therapeutics, Inc.
KYMR
director
96,397
0.1616%
$30.00$2.89M-11%
2022-11-02SaleKymera Therapeutics, Inc.
KYMR
director
123,619
0.223%
$30.02$3.71M-4.24%
2022-11-01SaleKymera Therapeutics, Inc.
KYMR
director
77,030
0.136%
$30.60$2.36M-7.8%
2022-10-31SaleKymera Therapeutics, Inc.
KYMR
director
120,622
0.2076%
$30.23$3.65M-8.7%
2022-10-28SaleKymera Therapeutics, Inc.
KYMR
director
91,050
0.1573%
$30.00$2.73M-7.5%
2022-01-11PurchaseVigil Neuroscience, Inc.
VIGL
director
535,000
2.3688%
$14.00$7.49M-24.96%
2021-08-11SaleKymera Therapeutics, Inc.
KYMR
director
484,266
1.0271%
$61.00$29.54M-27.25%
2021-03-12SaleKymera Therapeutics, Inc.
KYMR
director
458,700
1.0347%
$56.50$25.92M-6.59%
2018-02-13PurchaseViridian Therapeutics, Inc.
VRDN
director
1.09M
4.1192%
$5.50$6M+6.91%